MANUSO JAMES S J
Insider CIK 1236365 · OCUP Director · KTRA Director · CORX President and CEO, Director, 10% owner · ASTX President/CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRD Opus Genetics, Inc. | A Award | 2026-04-20 | 2026-04-22 | 24,367 | — | $0 | 317,318 | SEC↗ |
| HURA TuHURA Biosciences, Inc./N | A Award deriv | 2026-02-12 | 2026-02-17 | 156,240 | — | $0 | 156,240 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2026-01-01 | 2026-01-05 | 31,188 | — | $0 | 292,951 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award deriv | 2025-04-30 | 2025-05-02 | 79,592 | — | $0 | 79,592 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2025-04-30 | 2025-05-02 | 79,504 | — | $0 | 261,763 | SEC↗ |
| HURA TuHURA Biosciences, Inc./N | A Award deriv | 2025-01-02 | 2025-01-06 | 59,590 | — | $0 | 59,590 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2025-01-02 | 2025-01-06 | 50,222 | — | $0 | 182,259 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2024-10-18 | 2024-10-22 | 13,553 | — | $0 | 13,553 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2024-10-18 | 2024-10-22 | 13,553 | — | $0 | 13,553 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 35,181 | — | $0 | 35,181 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2024-06-11 | 2024-06-13 | 41,143 | — | $0 | 132,037 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2024-01-01 | 2024-01-03 | 22,090 | — | $0 | 90,894 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 9,639 | — | $0 | 9,639 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2023-06-06 | 2023-06-08 | 10,976 | — | $0 | 68,804 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2023-04-19 | 2023-04-21 | 2,819 | — | $0 | 57,828 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2023-01-11 | 2023-01-12 | 18,544 | — | $0 | 55,009 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | X Exercise deriv | 2022-10-11 | 2022-10-12 | 787 | — | $0 | 0 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | X Exercise | 2022-10-11 | 2022-10-12 | 787 | — | $0 | 36,465 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2022-07-01 | 2022-07-06 | 14,108 | — | $0 | 35,678 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy | 2022-05-20 | 2022-05-24 | 5,000 | $1.99 | $9.9K | 21,570 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy | 2021-11-18 | 2021-11-22 | 2,000 | $3.50 | $7.0K | 16,570 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2021-06-07 | 2021-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy deriv | 2020-11-19 | 2020-11-25 | 6,697 | — | $0 | 6,697 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy deriv | 2020-11-19 | 2020-11-25 | 787 | — | $0 | 787 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy | 2020-11-19 | 2020-11-25 | 4,434 | — | $0 | 14,570 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-11 | 2020-11-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-05 | 2020-11-09 | 52,825 | — | $0 | 52,825 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-05 | 2020-11-09 | 35,663 | — | $0 | 35,663 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2020-11-05 | 2020-11-09 | 10,136 | — | $0 | 10,136 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | J Other deriv | 2017-12-09 | 2017-12-12 | 608,704 | — | $0 | 608,704 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | P Buy deriv | 2017-09-13 | 2017-12-12 | 2,195 | — | $0 | 2,195 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | P Buy | 2017-09-13 | 2017-12-12 | 1,097 | — | $0 | 74,252 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | A Award deriv | 2017-06-30 | 2017-07-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | A Award deriv | 2017-01-18 | 2017-01-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | J Other deriv | 2016-04-07 | 2016-04-11 | 23,775,558 | — | $0 | 0 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | J Other deriv | 2016-04-07 | 2016-04-11 | 11,887,779 | — | $0 | 11,887,779 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | J Other | 2016-04-07 | 2016-04-11 | 11,887,779 | — | $0 | 23,775,558 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | A Award deriv | 2016-03-31 | 2016-04-04 | 26,500,000 | — | $0 | 26,500,000 | SEC↗ |
| RSPI RespireRx Pharmaceuticals | J Other deriv | 2016-02-04 | 2016-04-04 | 2,630,000 | — | $0 | 2,630,000 | SEC↗ |
| CORX CORTEX PHARMACEUTICALS INC | P Buy deriv | 2015-08-28 | 2015-08-31 | 23,775,558 | — | $0 | 23,775,558 | SEC↗ |
| CORX CORTEX PHARMACEUTICALS INC | P Buy | 2015-08-28 | 2015-08-31 | 11,887,779 | — | $0 | 11,887,779 | SEC↗ |
| CORX CORTEX PHARMACEUTICALS INC | A Award deriv | 2015-08-18 | 2015-08-20 | 80,000,000 | — | $0 | 80,000,000 | SEC↗ |
| CORX CORTEX PHARMACEUTICALS INC | A Award deriv | 2015-08-18 | 2015-08-20 | 5,081,300 | — | $0 | 5,081,300 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 360,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 360,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 360,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 800,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 360,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 360,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 1,200,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 250,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 250,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 200,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 360,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 1,000,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 360,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | U Tender | 2013-10-11 | 2013-10-16 | 13,900 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | U Tender | 2013-10-11 | 2013-10-16 | 70 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-09-04 | 2013-09-06 | 7,500 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-09-04 | 2013-09-06 | 7,500 | $5.69 | $42.7K | 13,900 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-05-14 | 2013-05-15 | 29,500 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | S Sale | 2013-05-14 | 2013-05-15 | 29,500 | $5.84 | $172.3K | 6,400 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-05-14 | 2013-05-15 | 29,500 | $4.03 | $118.9K | 35,900 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-05-02 | 2013-05-06 | 7,500 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-05-02 | 2013-05-06 | 30,500 | — | $0 | 29,500 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | S Sale | 2013-05-02 | 2013-05-06 | 38,000 | $5.87 | $223.1K | 6,400 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-05-02 | 2013-05-06 | 38,000 | $4.03 | $153.1K | 44,400 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | A Award deriv | 2013-04-01 | 2013-04-03 | 360,000 | — | $0 | 360,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-03-08 | 2013-03-12 | 40,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-03-08 | 2013-03-12 | 40,000 | $2.46 | $98.4K | 46,400 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | S Sale | 2013-03-08 | 2013-03-12 | 40,000 | $4.40 | $176.0K | 6,400 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | A Award deriv | 2012-09-28 | 2012-09-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | A Award deriv | 2012-04-02 | 2012-04-04 | 360,000 | — | $0 | 360,000 | SEC↗ |